Biohaven Pharma (BHVN) Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
Go back to Biohaven Pharma (BHVN) Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300| (NYSE: BHVN) | Delayed: 13.89 +1.87 (15.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.02 | 52 Week High | $ | |||
| Open | $12.18 | 52 Week Low | $ | |||
| Day High | $14.33 | P/E | N/A | |||
| Day Low | $12.05 | EPS | $ | |||
| Volume | 5,833,471 | |||||
